• After Decade at MHRA, Breckenridge to Step Aside

    The UK's Medicines and Healthcare products Regulatory Agency (MHRA) will have a new chairman as of 1 January 2013, the agency has announced. Professor Sir Gordon Duff will assume the position of chairman of MHRA on the first of the new year, replacing outgoing Chairman Sir Alasdair Breckenridge, whose term ends on 31 December 2012. The transition is a significant one for MHRA, as Breckenridge has been chairman of the agency since its inception in April 2003. Prior to ...
  • UK: Chair Appointed for UK's New Emerging Science and Bioethics Advisory Committee

    The Chair of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), Sir Alisdair Breckenridge, has been appointed the first Chair of the newly established Emerging Science and Bioethics Advisory Committee (ESBAC). The committee is tasked with providing advice to UK health departments on emerging healthcare scientific developments and their ethical, legal, social and economic implications.  Sir Alasdair's previous roles include Chair of the Committ...